Investigation of lysosomal storage diseases in nonimmune hydrops fetalis

Prenatal Diagnosis

Volumn 24, Issue 8, 2004, Pages 653-657

  Burin, Maira G ^a,b   Scholz, Ana P ^a   Gus, Rejane ^a   Sanseverino, Maria Teresa V ^a   Fritsh, Alessandra ^a   Magalhães, José A ^a   Timm, Fernanda ^a   Barrios, Patrícia ^a   Chesky, Marisa ^a   Coelho, Janice C ^a,b   Giugliani, Roberto ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Fetal ascites; Genetic counseling; Lysosomal storage disease; Nonimmune hydrops fetalis; Nuchal translucency

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONSANGUINITY; CONTROLLED STUDY; ENZYME ANALYSIS; FAMILY HISTORY; FETUS; FETUS HYDROPS; GALACTOSIALIDOSIS; GENETIC COUNSELING; HUMAN; LYSOSOME STORAGE DISEASE; MUCOLIPIDOSIS; MUCOPOLYSACCHARIDOSIS; NEWBORN; NIEMANN PICK DISEASE; PRENATAL PERIOD; PRIORITY JOURNAL; RARE DISEASE; SIALIDOSIS;

ADULT; FEMALE; HUMANS; HYDROPS FETALIS; LYSOSOMAL STORAGE DISEASES; MUCOLIPIDOSES; MUCOPOLYSACCHARIDOSIS IV; NIEMANN-PICK DISEASES; PREGNANCY;

HYDROPS;

EID: 4243125333     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.967     Document Type: Article

References (37)

1. Beaudet AL, Differrante NM, Ferry GD, Nichols BL, Mullins CE. 1975. Variations in the phenotypic expression of B-glucuronidase deficiency. J Pediatr 86: 388-394.
2. Ben-Haroush A, Yogev Y, Levit O, Hod M, Kaplan B. 2003. Isolated fetal ascites caused by Wolman disease. Ultrasound Obstet Gynecol 21: 297-298.
3. Bonduelle M, Lissens W, Goossens A, et al. 1991. Lysosomal storage diseases presenting as transient or persistent hydrops fetalis. Genet Couns 2: 227-232.
4. Bouvier R, Maire I. 1997. Diagnosis of lysosomal storage diseases with fetal presentation. Ann Pathol 17: 277-280.
5. Claeys M, Van der Hoeven M, de Die-Smulders C, et al. 1999. Early-infantile type of galactosialidosis as a cause of heart failure and neonatal ascites. J Inherit Metab Dis 22: 666-667.
6. De Jong JGN, Wevers RA, Liebrand-van Sambeek R. 1992. Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem 38: 803-807.
7. den Hollander NS, Kleijer WJ, Schoonderwaldt EM, Los FJ, Wladimiroff JW, Niermeijer MF. 2000. In-utero diagnosis of mucopolysaccharidosis type VII in a fetus with an enlarged nuchal translucency. Ultrasound Obstet Gynecol 16: 87-90.
8. Denis R, Wayenberg JL, Vermeulen M, et al. 1996. Hyperphosphatasemia in early diagnosed infantile GMI gangliosidosis presenting as transient hydrops fetalis. Acta Clin Belg 51: 320-327.
9. Geipel A, Berg C, Germer U, Krapp M, Kohl M, Gembruch U. 2002. Mucopolysaccharidosis VII (Sly disease) as a cause of increased nuchal translucency and non-immune hydrops fetalis: study of a family and technical approach to prenatal diagnosis in early and late pregnancy. Prenat Diagn 22: 493-495.
10. Godra A, Kim DU, D'Cruz C. 2003. Pathologic quiz case: a 5-day-old boy with hydrops fetalis. Mucolipidoses I (Sialidosis III). Arch Pathol Lab Med 127: 1051-1052.
11. Groener JE, de Graaf FL, Poorthuis BJ, Kanhai HH. 1999. Prenatal diagnosis of lysosomal storage diseases using fetal blood. Prenat Diagn 19: 930-933.
12. Guo Y, He W, Boer AM, et al. 1995. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis 18: 717-722.
13. Hopwood JJ, Muller V, Smithson A, Baggett N. 1979. A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes. Clin Chim Acta 92: 257-265.
14. Hutchison AA, Drew JH, Yu VY, Williams ML, Fortune DW, Beischer NA. 1982. Nonimmunologic hydrops fetalis: a review of 61 cases. Obstet Gynecol 59: 347-352.
15. Jauniaux E, Kaminopetros P, Rodeck C. 1998. Hydrops fetalis. In Body Fluids and Kidney Function, Brace RA, Hanson MA, Rodeck CH (eds). Cambridge University Press: Cambridge; 207-230.
16. Kattner E, Schafer A, Harzer K. 1997. Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr 156: 292-295.
17. Lefebvre G. 1999. Recurrent nonimmune hydrops fetalis a rare presentations of sialic acid storage disease. Genet Couns 10: 277-284.
18. Lipiello L, Mankin HJ. 1977. Thin-layer chromatographic separation of the isomeric chondroitin sulfates, dermatan sulfate and keratin sulfate. Anal Biochem 39: 54-58.
19. Lissens W, Dedobbeleer G, Foulon W, et al. 1991. Beta-glucuronidase deficiency as a cause of prenatally diagnosed non-immune hydrops fetalis. Prenat Diagn 11: 405-410.
20. Machin GA. 1997. Hydrops, cystic hygroma, hydrothorax, pericardial effusions and fetal ascites. In Pathology of the Fetus and Infant, Gilbert-Barness E (ed.). Mosby: St Louis; 163-181.
21. Meizner I, Levy A, Carmi R, Robinsin C. 1990. Niemann-Pick disease associated with nonimmune hydrops fetalis. Am J Obstet Gynecol 163: 128-129.
22. O'Brien JS, Warner TG. 1980. Sialidosis: delineation of subtypes by neuraminidase assay. Clin Genet 17: 35-38.
23. Pentchev PG, Gal AE, Booth AD, et al. 1980. A lysosomal storage disorder in mice characterized by a dual deficiency of sphingomyelinase and glucocerebrosidase. Biochim Biophys Acta 619: 669-679.
24. Peters SP, Coyle P, Glew RH. 1976. Differentiation of β-glucocerebrosidase form β-glucosidase in human tissues using sodium taurocholate. Arch Biochem Biophys 175: 569-572.
25. Piraud M, Froissart R, Mandon G, Bernard A, Maire I. 1996. Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis). Clin Chim Acta 248: 143-155.
26. Prence EMNMR. 1992. Diagnosis of alpha-mannosidosis by measuring of alpha-mannosidase in plasma. Clin Chem 38: 501-503.
27. Saxonhouse MA, Behnke M, Williams JL, Richards D, Weiss MD. 2003. Mucopolysaccharidosis type VII presenting with isolated neonatal ascites. J Perinatol 23: 73-75.
28. Sewell A. 1979. An improved thin-layer chromatographic method for urinary oligosaccharide screening. Clin Chim Acta 92: 411-444.
29. Singer JDCE, Krimmer R. 1973. Hexosaminidase A in tears and saliva for rapid identification of Tay-Sachs disease and its carriers. Lancet 2: 1116-1119.
30. Skoog WA, Beck WS. 1956. Studies on the fibrinogen, dextran and phytohemaglutinin methods of isolating leukocytes. Blood 11: 436-454.
31. Skoza MMS. 1976. Stable thiobarbituric acid chromofore with dimethylsulphoxide. Application to sialic acid assay in analytical de-o-acetylation. Biochem J 159: 457-462.
32. Stone DL, Sidransky E. 1999. Hydrops fetalis: lysosomal storage disorders in extremis. Adv Pediatr 46: 409-440.
33. Suzuki K. 1977. Globoid Cell Leukodystrophy (Krabbe Disease) and GM1 Gangliosidosis. Liss A. L: New York.
34. Tokieda K, Morikawa Y, Natori M, Hayashida S, Mori K, Ikeda K. 1998. Intrauterine growth acceleration in the case of a severe form of mucopolysaccharidosis type VII. J Perinat Med 26: 235-239.
35. van Diggelen OP, Zhao H, Kleijer WJ, et al. 1990. A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IVA). Clin Chim Acta 187: 131.
36. Wraith JE. 2002. Lysosomal disorders. Semin Neonatol 7: 75-83.
37. Zammarchi E, Donati MA, Morrone A, Donzelli GP, Zhou XY, d'Azzo A. 1996. Early-infantile galactosialidosis: clinical, biochemical, and molecular observations in a new patient. Am J Med Genet 64: 453-458.